Too much stock is put into the cc’s Cytodyn has

Too much stock is put into the cc’s Cytodyn has by the investors. They are scheduled at least once a month by NP to keep retail investors as “ on the rails” as much as possible. People looking for a Big Bang in these meetings are perpetually disappointed because this isn’t the purpose of the meetings. As a company on the OTC, without major investment firms invested in OTC stocks, NP believes, as I do, he needs to keep retail investors informed on progress. He even said once the company is on the NASDAQ, these meeting would move to a more normal once a quarter type meeting. updates. These meetings are progress reports; not major announcements so I think the expectation of a Big Bang needs to be tamped down. We are moving thru clinical trials quickly . We went into phase 3 in April and we will be finished with phase 3 in less than a year. That’s a big deal and those on this board in Biotech and who understand how the FDA functions know that.